within Pharmacolibrary.Drugs.ATC.A;

model A07AC01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.24,
    Cl             = 1.8e-05,
    adminDuration  = 600,
    adminMass      = 500 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0348,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0018333333333333333,
    Tlag           = 1200
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A07AC01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Miconazole is an imidazole antifungal medication, primarily used for the treatment of fungal infections. It is effective against dermatophytes and yeast infections, and is often used in the treatment of candidiasis in the oral, gastrointestinal, and vaginal regions. Miconazole is approved and widely used today in topical and oral forms.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers after oral administration of miconazole.</p><h4>References</h4><ol><li><p>Hynninen, VV, et al., &amp; Laine, K (2009). Oral voriconazole and miconazole oral gel produce comparable effects on the pharmacokinetics and pharmacodynamics of etoricoxib. <i>European journal of clinical pharmacology</i> 65(1) 89–95. DOI:<a href=\"https://doi.org/10.1007/s00228-008-0556-9\">10.1007/s00228-008-0556-9</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/18777173/\">https://pubmed.ncbi.nlm.nih.gov/18777173</a></p></li><li><p>Grönlund, J, et al., &amp; Laine, K (2011). Miconazole oral gel increases exposure to oral oxycodone by inhibition of CYP2D6 and CYP3A4. <i>Antimicrobial agents and chemotherapy</i> 55(3) 1063–1067. DOI:<a href=\"https://doi.org/10.1128/AAC.01242-10\">10.1128/AAC.01242-10</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/21173180/\">https://pubmed.ncbi.nlm.nih.gov/21173180</a></p></li><li><p>Cardot, JM, et al., &amp; Aiache, JM (2004). Comparison of the pharmacokinetics of miconazole after administration via a bioadhesive slow release tablet and an oral gel to healthy male and female subjects. <i>British journal of clinical pharmacology</i> 58(4) 345–351. DOI:<a href=\"https://doi.org/10.1111/j.1365-2125.2004.02154.x\">10.1111/j.1365-2125.2004.02154.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/15373926/\">https://pubmed.ncbi.nlm.nih.gov/15373926</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A07AC01;
